<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03605914</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-18-0242</org_study_id>
    <nct_id>NCT03605914</nct_id>
  </id_info>
  <brief_title>Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty</brief_title>
  <official_title>Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the level of pain control in patients receiving
      non-steroidal anti-inflammatory drugs (NSAIDs) to those receiving opioids in the
      postoperative period after endoscopic sinus surgery (ESS) and/or septoplasty.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score as assessed by a 100mm visual analogue scale (VAS)</measure>
    <time_frame>24 hours</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score as assessed by a 100mm visual analogue scale (VAS)</measure>
    <time_frame>48 hours</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score as assessed by a 100mm visual analogue scale (VAS)</measure>
    <time_frame>72 hours</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score as assessed by a 100mm visual analogue scale (VAS)</measure>
    <time_frame>120 hours</time_frame>
    <description>The range of scores on the VAS is 0 to 100, with 100 being the highest level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with bleeding complications</measure>
    <time_frame>5 days after operation</time_frame>
    <description>Bleeding complications are defined as complications necessitating a trip to the emergency room or requiring intervention for epistaxis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with constipation</measure>
    <time_frame>5 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with nausea or vomiting</measure>
    <time_frame>5 days after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty</condition>
  <arm_group>
    <arm_group_label>NSAID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclofenac</intervention_name>
    <description>The non-steroidal anti-inflammatory drug (NSAID) used in this study is diclofenac.</description>
    <arm_group_label>NSAID</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norco</intervention_name>
    <description>The opioid used in this study is Norco. Norco is a combination medication that contains both an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen).</description>
    <arm_group_label>opioid</arm_group_label>
    <other_name>Hydrocodone-Acetaminophen combination medication</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  english speaking

          -  candidates for endoscopic sinus surgery as determined by medical necessity by the
             treating rhinologist

          -  scheduled for surgery at Texas Sinus Institute

        Exclusion Criteria:

          -  allergy to either NSAIDs or opioids

          -  contraindication to NSAIDs (ex. gastritis, chronic kidney disease)

          -  surgical plan exceeding basic endoscopic sinus surgery

          -  use of anticoagulation

          -  the presence of any pain disorder

          -  the current usage of any analgesic medication

          -  history of opioid addiction

          -  pregnancy

          -  history of chronic pain or fibromyalgia

          -  current daily use of NSAIDs, acetaminophen, opioids or other analgesics (pregabalin,
             tramadol, etc)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Citardi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin J Citardi, MD</last_name>
    <phone>(713) 500-5410</phone>
    <email>Martin.J.Citardi@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin J Citardi, MD</last_name>
      <phone>713-500-5410</phone>
      <email>Martin.J.Citardi@uth.tmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2018</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Martin J Citardi, MD</investigator_full_name>
    <investigator_title>Professor and Chairman, Department of Otorhinolaryngology - Head and Neck Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

